Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Harmony Gold Mining
HMY
$12.1B
| $46.7M | 0.04% |
11,205,720
-2,892,047
| -21% | -$9.52M |
|
|
CWEN.A
452
DELISTED
Clearway Energy Class A
CWEN.A
| $46.6M | 0.04% |
2,221,630
+32,364
| +1% | +$632K |
|
|
SGEN
453
DELISTED
Seagen Inc. Common Stock
SGEN
| $46.6M | 0.04% |
274,113
+254,813
| +1,320% | +$38M |
|
454
DHT Holdings
DHT
$3.1B
| $46.4M | 0.04% |
9,047,619
-1,107,750
| -11% | -$7.06M |
|
|
GOOD
455
Gladstone Commercial Corp
GOOD
$639M
| $46.4M | 0.04% |
2,474,015
-106,085
| -4% | -$1.74M |
|
456
Nutrien
NTR
$32.1B
| $46.3M | 0.04% |
1,441,785
+656,400
| +84% | +$22.8M |
|
457
Nice
NICE
$6.15B
| $46.1M | 0.04% |
243,563
+105,119
| +76% | +$18.4M |
|
458
Omnicom Group
OMC
$24.2B
| $45.7M | 0.04% |
837,200
+633,919
| +312% | +$34.5M |
|
459
CDW
CDW
$17.7B
| $45.4M | 0.04% |
390,598
+162,400
| +71% | +$17.6M |
|
460
Fidelity National Financial
FNF
$13.1B
| $45.2M | 0.04% |
1,532,345
+423,377
| +38% | +$11.6M |
|
461
OraSure Technologies
OSUR
$277M
| $45.2M | 0.04% |
3,884,150
+81,340
| +2% | +$1.06M |
|
462
Paychex
PAYX
$44.6B
| $45.1M | 0.04% |
595,601
+386,500
| +185% | +$26.8M |
|
463
SLB Ltd
SLB
$77.4B
| $45M | 0.04% |
2,447,204
-1,381,900
| -36% | -$24.2M |
|
|
NSA
464
DELISTED
National Storage Affiliates Trust
NSA
| $45M | 0.04% |
1,569,602
-277,700
| -15% | -$7.96M |
|
465
UnitedHealth
UNH
$358B
| $45M | 0.04% |
152,426
+99,100
| +186% | +$28.4M |
|
|
PTR
466
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $44.8M | 0.04% |
1,355,147
+86,100
| +7% | +$3.04M |
|
467
CVR Energy
CVI
$3.56B
| $44.8M | 0.04% |
2,225,384
-539,200
| -20% | -$10.9M |
|
|
PGTI
468
DELISTED
PGT, Inc.
PGTI
| $44.7M | 0.04% |
2,850,229
-298,200
| -9% | -$3.59M |
|
|
IMGN
469
DELISTED
Immunogen Inc
IMGN
| $44.5M | 0.04% |
9,665,139
-1,350,990
| -12% | -$5.75M |
|
470
Western Union
WU
$2.31B
| $44.3M | 0.04% |
2,051,300
-73,376
| -3% | -$1.49M |
|
471
National Healthcare
NHC
$3.45B
| $44.3M | 0.04% |
699,000
+33,200
| +5% | +$2.23M |
|
472
Prologis
PLD
$134B
| $44M | 0.04% |
+471,914
| New | +$42.1M |
|
473
Patterson-UTI
PTEN
$4.14B
| $44M | 0.04% |
12,683,157
+132,998
| +1% | +$459K |
|
474
Eaton
ETN
$176B
| $44M | 0.04% |
+502,711
| New | +$41.4M |
|
475
Planet Fitness
PLNT
$3.69B
| $43.9M | 0.04% |
+725,000
| New | +$43.5M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.